Assessing Decision Maker Tools for Asthma: the Asthma APGAR
Asthma APGAR
1 other identifier
interventional
1,500
1 country
1
Brief Summary
Asthma is a common problem among US adults and children. Unfortunately many people with asthma continue to suffer from asthma symptoms that could be control with better asthma care and more attention to details such as triggers, and adherence. To date the only tools available and recommended by groups such as the national asthma guideline group consider only asthma burden and do not include information on the most common factors that adversely affect asthma control. This study provides one half of the enrolled primary care offices with the Asthma APGAR which is a system of patient completed questions and a care flow sheet. The other half of the enrolled practices will continue to provide "usual" care without the support of the Asthma APGAR system. The research questions is whether or not asthma control and asthma related quality of life will be improved in people with asthma who are cared for in the intervention practices that use the Asthma APGAR system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 asthma
Started Oct 2011
Typical duration for phase_4 asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 3, 2011
CompletedFirst Posted
Study publicly available on registry
October 5, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedOctober 5, 2011
October 1, 2011
3 years
October 3, 2011
October 4, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma Quality of Life Questionnaire (AQLQ)
Chagne in asthma relted quality of life from basline (enrollment date) to 12 months later
12 months
Secondary Outcomes (2)
Asthma Control Questionnaire
12 months
Exacerbation rate
12 months
Study Arms (2)
Asthma APGAR
EXPERIMENTALUse of new asthma care tools. Primary care practices will be provided and educated about the Asthma APGAR tool system to guide asthma care. The practices will adopt this system for all people in their practices with asthma. Outcomes will be assessed only for those who meet enrollment criteria and sign informed consent.
Usual care
PLACEBO COMPARATORUsual asthma care as provided by the sites.
Interventions
Practices will use the Asthma APGAR control questionnaire and the care algorithm.
Eligibility Criteria
You may qualify if:
- Have physician diagnosed asthma
- Male or female between ages 5 through 60 years
- Have persistent asthma as assessed by daily use of "controller" medication
- Receive continuity care at practice where enrolled.
- Not have been in ICU for asthma ever
- Do not require daily or every other day oral steroids for asthma control
You may not qualify if:
- Cannot read and speak English
- Child refuses assent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Olmsted Medical Center
Rochester, Minnesota, 55904, United States
Related Publications (2)
Yawn BP, Wollan PC, Rank MA, Bertram SL, Juhn Y, Pace W. Use of Asthma APGAR Tools in Primary Care Practices: A Cluster-Randomized Controlled Trial. Ann Fam Med. 2018 Mar;16(2):100-110. doi: 10.1370/afm.2179.
PMID: 29531100DERIVEDRank MA, Bertram S, Wollan P, Yawn RA, Yawn BP. Comparing the Asthma APGAR system and the Asthma Control Test in a multicenter primary care sample. Mayo Clin Proc. 2014 Jul;89(7):917-25. doi: 10.1016/j.mayocp.2014.02.016. Epub 2014 May 5.
PMID: 24809759DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara P Yawn, MD MSc
Olmsted Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Research
Study Record Dates
First Submitted
October 3, 2011
First Posted
October 5, 2011
Study Start
October 1, 2011
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
October 5, 2011
Record last verified: 2011-10